✕ Close Details
Indications - Empagliflozin & Linagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Dosage & Administration - The recommended dose is Empagliflozin & Linagliptin 10/ 5 once daily, taken in the morning, with or without food. Dose may be increased to Empagliflozin & Linagliptin 25/5 once daily.
Side Effects - Data note update
Contraindications - Data note update
Others - Data note update
Tablet Glympa 25 mg+5mg
- Brand Name - Glympa 25/5
- Generic Name - Empagliflozin & Linagliptin
- Doges From - Tablet
- Strength - 25 mg+5 mg
- Pack Size - 10s
- Manufacture - Square Pharmaceutical Ltd.
Customers who bought this item also bought
